Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  allogeneic natural killer cell line NK-92
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Personalized NK Cell Therapy after Chemotherapy and Cord Blood Transplant in Treating Patients with Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
Status: Active
Phase: Phase II
Type: Treatment
Age: 80 and under
Trial IDs: 2015-0313, NCI-2016-00584, NCT02727803
Start Over